Aalborg Universitetshospital er det største hospital/sygehus i Nordjylland. Aalborg Universitetshospital omfatter matriklerne Syd og Nord i Aalborg, matriklerne Farsø, Hobro og Thisted - samt en række satellitmatrikler i Aalborg på Havrevangen, Vesterbro, Kastetvej, Fåborgvej og Nybrovej.

During the past decade, Department of Neurology, Aalborg University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Neurology, Aalborg University Hospital" #1 collaborator was "Aalborg University Hospital" with 2 trials as a collaborator, "Aarhus University Hospital" with 2 trials as a collaborator, "Odense University Hospital" with 2 trials as a collaborator, "Danske Regioner" with 1 trials as a collaborator and "GCP unit, Copenhagen University Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Department of Neurology, Aalborg University Hospital" are "CIDP - Chronic Inflammatory Demyelinating Polyneuropathy" (1 trials), "Myasthenia Gravis" (1 trials), "Primary Progressive Multiple Sclerosis" (1 trials), "Relapsing Remitting Multiple Sclerosis" (1 trials) and "Secondary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Department of Neurology, Aalborg University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Neurology, Aalborg University Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fexofenadine" (1 trials), "Immunoglobulin" (1 trials), "Methylprednisolone" (1 trials), "Ocrelizumab" (1 trials) and "Paracetamol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Neurology, Aalborg University Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurology, Aalborg University Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Neurology, Aalborg University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurology, Aalborg University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".